Asymptomatic cutaneous polyarteritis nodosa: Treatment options and therapeutic guidelines

Kate Ross, Jessika Contreras, David Aung-Din, Mary Lien

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Cutaneous polyarteritis nodosa (CPAN) is a rare cutaneous small- to medium-vessel vasculitis of unknown etiology. Clinically it ranges in manifestation from livedo reticularis to large cutaneous ulcers and necrosis. Prognosis is favorable and progression to systemic polyarteritis nodosa is rare. There are multiple treatment options, none of which have proven to be definitively effective. Cutaneous polyarteritis nodosa has been associated with abnormal antibody testing with elevations of antiphospholipid cofactor antibody, lupus anticoagulant, anticardiolipin antibody, and anti-β2-glycoprotein I-dependent cardiolipin antibodies, as well as elevated anti-phosphatidylserine-prothrombin complex antibody. These antibodies suggest increased risk for thrombosis and systemic diseases such as lupus or other autoimmune connective tissue disease. We present a case of asymptomatic CPAN and evaluate if treatment should be instituted for asymptomatic disease that presents with abnormal antibody findings.

Original languageEnglish
Pages (from-to)125-128
Number of pages4
Issue number2
StatePublished - Aug 1 2017


Dive into the research topics of 'Asymptomatic cutaneous polyarteritis nodosa: Treatment options and therapeutic guidelines'. Together they form a unique fingerprint.

Cite this